-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$14.132617.31% Upside
bluebird bio, Inc. Frequently Asked Questions
-
What analysts cover bluebird bio, Inc.?
bluebird bio, Inc. has been rated by research analysts at Barclays, Wedbush, J.P. Morgan, Berenberg Bank, Goldman Sachs, Evercore ISI in the past 90 days.